Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.

Autor:	Lim, Samuel Hsiang, Gros, Beatriz, Sharma, Esha, Lehmann, Anouk, Lindsay, James O, Caulfield, Louise, Gaya, Daniel R, Taylor, Jo, Limdi, Jimmy, Kwok, Jon, Shuttleworth, Elinor, Dhar, Anjan, Burdge, Gemma, Selinger, Christian, Cococcia, Sara, Murray, Charles, Balendran, Karthiha, Raine, Tim, George, Becky, Walker, Gareth
Zdroj:	Inflammatory Bowel Diseases; Aug2024, Vol. 30 Issue 8, p1284-1294, 11p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu